“…Thereby, multiple public in silico spectral databases were used, i.e., GNPS, SUPNAT, NPAtlas, CHEBI, and DRUGBANK. Additionally, an Eremophila ‐specific in‐house in silico fragmentation database was used that contains 293 metabolite structures that have been characterized in Eremophila species during prior studies (Pedersen et al., 2019 , 2020 ; Singab et al., 2013 ; Zhao et al., 2019 ; Zhao et al., unpublished data). The in silico fragmentation‐based dereplication results were categorized by their reliability, with SMILES from Fusion, Consensus, and MetFrag algorithms corresponding to level 3a, 3b, and 3c identification, respectively.…”